High levels of MYO9B have been shown to promote actin reorganization by reducing filaments and to stimulate metastasis by breaking down stress fibers and reducing cell adhesion, thereby enhancing the cancer phenotype in both prostate [89] and lung cancer [108]. Here, MYO9B is linked to lung carcinoma.